NasdaqGS - Nasdaq Real Time Price USD

IDEXX Laboratories, Inc. (IDXX)

440.98

+14.35

+(3.36%)

At close: April 24 at 4:00:00 PM EDT

440.00

-0.98

(-0.22%)

Pre-Market: 4:35:28 AM EDT

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 19 hours ago

IDXX
+3.36%
Idexx Laboratories price target lowered to $475 from $535 at BofA

BofA lowered the firm’s price target on Idexx Laboratories (IDXX) to $475 from $535 and keeps a Neutral rating on the shares. Heading into Q1 earnings, the firm says sentiment on its animal health coverage “skews generally negative,” with a number of broader market and company-specific headwinds. The firm sees limited near-term catalysts to drive estimates higher beyond improved foreign exchange rates, so it thinks shares will remain capped near current levels, the analyst added in a preview for

TipRanks 2 days ago

IDXX
+3.36%
IDXX Gears Up for Q1 Earnings: What to Expect From the Stock?

IDEXX Laboratories' first-quarter 2025 performance is expected to have benefited from a strong execution against strategic priorities.

Zacks 3 days ago

IDXX
+3.36%
IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains?

IDEXX (IDXX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks 15 days ago

IDXX
+3.36%
IDEXX Laboratories (NasdaqGS:IDXX) Price Moves -14% Over The Last Week Amid Market Volatility

IDEXX Laboratories (NasdaqGS:IDXX) experienced a 14% decline over the last week, in line with the broader market turmoil where the S&P 500 fell by 12% amid heightened tariff tensions between the U.S. and China. The recent market volatility, driven by the imposition of new tariffs and China’s retaliatory measures, has largely weighed on various sectors, including healthcare and technology, which impact IDEXX's operational landscape. While some sectors like technology managed gains due to...

Simply Wall St. 15 days ago

IDXX
+3.36%
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 15 days ago

IDXX
+3.36%
Should You Sell IDEXX Laboratories (IDXX)?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, the strategy returned -1.35% (gross) and -1.56% (net) compared to 8.14% for the Russell Midcap Growth Index. In the fourth quarter, the U.S. small […]

Insider Monkey 17 days ago

IDXX
+3.36%
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks 20 days ago

IDXX
+3.36%
Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Zacks 20 days ago

IDXX
+3.36%
CAH
IDEXX Laboratories to Release 2025 First Quarter Financial Results

WESTBROOK, Maine, April 03, 2025--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 first quarter financial results for Thursday, May 1, 2025, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Business Wire 21 days ago

IDXX
+3.36%
Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000

Healthcare diagnostics equipment manufacturer, Idexx Laboratories (NASDAQ: IDXX), is the global leader in pet care. Despite this incredible run, Idexx's current share price is the same as it was in late 2020, despite revenue growing by 50% and free cash flow (FCF) per share rising 87% over the same period. This divergence between a company's improving financial results and its languishing share price is often a powerful combination for investors -- and I believe that could be the case with Idexx.

Motley Fool 26 days ago

IDXX
+3.36%
^GSPC
Is IDEXX Laboratories, Inc. (IDXX) The Best Pet Stock to Buy According to Billionaires?

We recently compiled a list of the 8 Best Pet Stocks to Buy According to Billionaires. In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against the other pet stocks. The pet industry is expected to continue growing in the coming years, driven by changing consumer preferences […]

Insider Monkey 29 days ago

IDXX
+3.36%
Why IDEXX Laboratories, Inc. (IDXX) is Among the Best Diagnostics Stocks to Invest in Right Now

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against the other best diagnostics stocks to invest in right now. Overview of the Clinical Diagnostics Market According to a report by […]

Insider Monkey last month

IDXX
+3.36%
IDEXX Laboratories Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution

In the last year, many IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) insiders sold a substantial stake in the company which...

Simply Wall St. last month

IDXX
+3.36%
Should You Retain IDEXX Stock in Your Portfolio for Now?

IDXX stays on investors' radar due to the strength of its CAG Diagnostics business.

Zacks last month

IDXX
+3.36%
CAH
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory

We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Hidden Market Gems. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc. (IDXX)’s share was trading at $426.69 as of March 11th. IDXX’s trailing and forward P/E were 39.98 and 36.36 respectively according to Yahoo Finance. IDEXX Laboratories, […]

Insider Monkey last month

IDXX
+3.36%
Corporate Buyers Sign Deals with Texas Solar Energy Projects

Technology company Cisco is among the groups involved in six virtual power purchase agreements (VPPAs) to secure energy from two solar power plants being developed in Texas.

POWER Magazine last month

CSCO

IDXX
+3.36%
Idexx (IDXX) Down 5% Since Last Earnings Report: Can It Rebound?

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

IDXX
+3.36%
IDEXX Laboratories Full Year 2024 Earnings: EPS Beats Expectations

IDEXX Laboratories ( NASDAQ:IDXX ) Full Year 2024 Results Key Financial Results Revenue: US$3.90b (up 6.5% from FY...

Simply Wall St. last month

IDXX
+3.36%
Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks

Every stock tells a story; it takes humans to find the meaning in it.

Motley Fool 2 months ago

AAPL

CPRT
+1.52%
ZTS
+0.92%

Performance Overview

Return	IDXX	S&P 500 (^GSPC)
YTD	+6.66%	-6.75%
1-Year	-10.78%	+8.15%
3-Year	-6.90%	+28.40%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

IDEXX Laboratories, Inc. (IDXX)

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

Idexx Laboratories price target lowered to $475 from $535 at BofA

IDXX Gears Up for Q1 Earnings: What to Expect From the Stock?

IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains?

IDEXX Laboratories (NasdaqGS:IDXX) Price Moves -14% Over The Last Week Amid Market Volatility

Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock

Should You Sell IDEXX Laboratories (IDXX)?

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

IDEXX Laboratories to Release 2025 First Quarter Financial Results

Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000

Is IDEXX Laboratories, Inc. (IDXX) The Best Pet Stock to Buy According to Billionaires?

Why IDEXX Laboratories, Inc. (IDXX) is Among the Best Diagnostics Stocks to Invest in Right Now

IDEXX Laboratories Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution

Should You Retain IDEXX Stock in Your Portfolio for Now?

IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory

Corporate Buyers Sign Deals with Texas Solar Energy Projects

Idexx (IDXX) Down 5% Since Last Earnings Report: Can It Rebound?

IDEXX Laboratories Full Year 2024 Earnings: EPS Beats Expectations

Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks

Performance Overview